BCM2-Body Composition Monitor— 510(k) K250634
Substantially EquivalentFresenius Medical Care Renal Therapies Group, LLC
FDA 510(k) clearance K250634 for BCM2-Body Composition Monitor, Substantially Equivalent on 2025-11-24. Applicant: Fresenius Medical Care Renal Therapies Group, LLC.
Clearance details
- Applicant
- Fresenius Medical Care Renal Therapies Group, LLC
- Product code
- Code DSB
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Waltham, MA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.